- Home
- DDD vs DCTH Comparison
DDD vs DCTH Comparison
Compare DDD & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DDD | DCTH |
|---|---|---|
| Founded | 1986 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 343.2M | 372.5M |
| IPO Year | 2003 | 2015 |
Fundamental Metrics
Financial Performance| Metric | DDD | DCTH |
|---|---|---|
| Price | $3.21 | $11.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $4.75 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 5.5M | 508.5K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 109.79 | 107.53 |
| EPS | N/A | N/A |
| Revenue | ★ $386,902,000.00 | N/A |
| Revenue This Year | $2.48 | $24.54 |
| Revenue Next Year | $4.10 | $33.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.50 | $8.12 |
| 52 Week High | $4.12 | $14.62 |
Technical Indicators
Market Signals| Indicator | DDD | DCTH |
|---|---|---|
| Relative Strength Index (RSI) | 55.52 | 58.54 |
| Support Level | $2.77 | $10.31 |
| Resistance Level | $3.42 | $12.34 |
| Average True Range (ATR) | 0.27 | 0.57 |
| MACD | -0.06 | 0.09 |
| Stochastic Oscillator | 31.72 | 75.83 |
Price Performance
Historical ComparisonAbout DDD 3D Systems Corporation
3D Systems Corp provide comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, manufacturing and applications engineering. Its solutions support applications in two key industry verticals: Healthcare Solutions provide surgical planning, implants, instrumentation, and medical education solutions to help medical device manufacturers and healthcare providers accelerate, and ultimately, transform healthcare, and Industrial Solutions which includes aerospace, defense, transportation and general manufacturing. The company operates in the Americas, EMEA, and APAC regions.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.